Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer

Author： Tuxen M. K.   Sölétormos G.   Rustin G. J. S.   Nelstrop A. E.   Dombernowsky P.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.60, Iss.8, 2000-12, pp. : 713-721

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer

By  

International Federation of Gynecology and Obstetrics, Vol. 140, Iss. 2, 2018-02 ,pp. : 247-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

CA-125 Monitoring in Ovarian Cancer: Patient Survey Responses to the Results of the MRC/EORTC CA-125 Surveillance Trial

By  

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 172-174

Karger

Access to resources Recommend Favorite

A Vexing CA 125 Raise in a Patient with Pleural Effusion and Ovarian Cancer

By  

Respiration, Vol. 94, Iss. 3, 2017-07 ,pp. : 312-312

Karger

Access to resources Recommend Favorite

Ovarian cancer early detection by circulating CA125 in the context of anti‐CA125 autoantibody levels: Results from the EPIC cohort

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1355-1360

John Wiley & Sons Inc

Access to resources Recommend Favorite